Lippincott, Williams & Wilkins, Journal of Acquired Immune Deficiency Syndromes, 5(66), p. 484-486, 2014
DOI: 10.1097/qai.0000000000000222
Full text: Download
ATP-binding cassette transporter G2 (ABCG2) is expressed on the cerebrospinal fluid (CSF) side of choroid plexus epithelial cells, which form the blood-CSF barrier. Raltegravir was recently identified as a substrate of ABCG2. In the present study, we analyzed the relationship between single nucleotide polymorphisms of ABCB1 and ABCG2 genes and raltegravir concentrations in 31 plasma and 14 CSF samples of HIV-infected patients treated with raltegravir-containing regimens. The mean CSF raltegravir concentration was significantly lower in CA (25.5 ng/ml) and AA (<10 ng/ml) genotypes at position 421 in ABCG2 gene compared to CC (103.6 ng/ml) genotype holders (p=0.016).